NCT00973622

Brief Summary

This study will examine the effects of high frequency, repetitive Transcranial Magnetic Stimulation (rTMS) on decision-making and smoking behavior.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
66

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started Oct 2009

Typical duration for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

August 26, 2009

Completed
14 days until next milestone

First Posted

Study publicly available on registry

September 9, 2009

Completed
22 days until next milestone

Study Start

First participant enrolled

October 1, 2009

Completed
2.3 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

January 1, 2012

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

January 1, 2012

Completed
1.7 years until next milestone

Results Posted

Study results publicly available

September 24, 2013

Completed
Last Updated

September 24, 2013

Status Verified

July 1, 2013

Enrollment Period

2.3 years

First QC Date

August 26, 2009

Results QC Date

January 23, 2013

Last Update Submit

July 31, 2013

Conditions

Keywords

Tobacco cessationTobacco dependenceTranscranial Magnetic StimulationNicotine DependenceDelayed Discounting

Outcome Measures

Primary Outcomes (1)

  • A Difference Score for the Log Value of K.

    K is a output value, a summary statistic, derived from a hyperbolic function that summarizes the rate at which monetary values are discounted according to the time they are received. The value of K can either increase or decrease from its baseline value. For example, an increase in K would indicate that the participant is choosing to receive larger amounts of money at a later point in time. A decrease would suggest the opposite - lesser amounts of money at an earlier point in time). The difference score is calculated from baseline to that immediately after 10 or 20 Hz rTMS.

    baseline and immediately after stimulation, an average of 25 seconds.

Study Arms (2)

Smokers

EXPERIMENTAL

Healthy adult smokers aged 19-55 who are not currently interested in quitting smoking.

Device: repetitive transcranial magnetic stimulation (rTMS) 10 Hertz (Hz)Device: repetitive transcranial magnetic stimulation (rTMS) 20HzDevice: SHAM repetitive transcranial magnetic stimulation (rTMS)

Non-smokers

EXPERIMENTAL

Healthy adult non-smokers aged 19-55

Device: repetitive transcranial magnetic stimulation (rTMS) 10 Hertz (Hz)Device: repetitive transcranial magnetic stimulation (rTMS) 20HzDevice: SHAM repetitive transcranial magnetic stimulation (rTMS)

Interventions

All participants will receive 90 10-pulse trains of 1 sec duration with an interval of 20 seconds. Smokers will receive the treatment twice, once in a nicotine-satiated condition, and once in a nicotine-withdrawal condition.

Also known as: "TMS" or Transcranial Magnetic Stimulation
Non-smokersSmokers

All participants will receive 45 20-pulse trains of 1 second duration with an interval of 20 seconds. Smokers will receive the treatment twice, once in a nicotine-satiated condition, and once in a nicotine-withdrawal condition.

Also known as: "TMS" or Transcranial Magnetic Stimulation
Non-smokersSmokers

The look and sound of active rTMS is reproduced with the same coil used in the active conditions. The magnetic field in the sham coil is markedly attenuated at only 5% of stimulator output. The feel of active stimulation will be reproduced by delivering monophasic current pulses to the left, frontalis muscle with a Isolated Stimulator and two carbon rubber electrodes. Smokers will receive Sham rTMS in both the nicotine-satiated and nicotine-withdrawal conditions.

Also known as: "TMS" or Transcranial Magnetic Stimulation
Non-smokersSmokers

Eligibility Criteria

Age19 Years - 55 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64)

You may qualify if:

  • Age 19-55
  • Must speak English
  • Must be right handed
  • Must pass the Transcranial Magnetic Stimulation Adult Safety and Screening Questionnaire (TAAS)
  • Smoking participants must be highly dependent with a score of 6 or greater on the Fagerstrom Test for Nicotine Dependence

You may not qualify if:

  • Positive test for drugs of abuse
  • Positive pregnancy test
  • A personal or family history of epilepsy
  • A history of anticonvulsant medication use
  • A personal history of head injury
  • A history of aneurysm, stroke, or previous cranial neurosurgery
  • A diagnosis of bipolar disorder
  • A neurological or psychiatric disorder for which hospitalization was required
  • Tinnitus
  • Metal implants in the head, neck or cochlea
  • A pacemaker
  • Migraines
  • A history of taking medications that lower seizure threshold (i.e. such as tricyclic antidepressants or bupropion)
  • Claustrophobia (due to the MRI)
  • Used any form of tobacco in the past two years if they desire to be a non-smoking participant
  • +3 more criteria

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

University of Arkansas for Medical Sciences

Little Rock, Arkansas, 72205, United States

Location

MeSH Terms

Conditions

Tobacco Use DisorderTobacco Use Cessation

Interventions

Transcranial Magnetic Stimulation

Condition Hierarchy (Ancestors)

Substance-Related DisordersChemically-Induced DisordersMental DisordersHealth BehaviorBehavior

Intervention Hierarchy (Ancestors)

Magnetic Field TherapyTherapeutics

Limitations and Caveats

We experienced significant subject attrition among smokers. We did not experience such attrition among nonsmokers. Also, six smokers were withdrawn because the MRI screen revealed brain abnormalities. No nonsmokers were withdrawn for this reason.

Results Point of Contact

Title
Christine Sheffer, PhD
Organization
University of Arkansas for Medical Sciences

Study Officials

  • Christine E Sheffer, PhD

    University of Arkansas

    PRINCIPAL INVESTIGATOR

Publication Agreements

PI is Sponsor Employee
No
Restrictive Agreement
No

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NON RANDOMIZED
Masking
DOUBLE
Who Masked
PARTICIPANT, INVESTIGATOR
Purpose
BASIC SCIENCE
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

August 26, 2009

First Posted

September 9, 2009

Study Start

October 1, 2009

Primary Completion

January 1, 2012

Study Completion

January 1, 2012

Last Updated

September 24, 2013

Results First Posted

September 24, 2013

Record last verified: 2013-07

Locations